Table 3.
Outcome measures between comatose vs. non-comatose patients.
| Outcome, n (%) | All (n = 259) | Non-comatose (n = 156, 60.2%) | Comatose (n = 103, 39.8%) | p |
|---|---|---|---|---|
| 90-day mRS | ||||
| mRS 0–2 | 88 (34.6%) | 76 (50.3%) | 12 (11.7%) | <0.001 |
| mRS 0–3 | 114 (44.9%) | 93 (61.6%) | 21 (20.4%) | <0.001 |
| mRS 5–6 | 118 (46.5%) | 43 (28.5%) | 75 (72.8%) | <0.001 |
| Dead at 3 months | 98 (38.3%) | 37 (24.2%) | 61 (59.2%) | <0.001 |
| Recanalization (TIMI 2–3)† | 155 (75.6%) | 98 (76.6%) | 57 (74.0%) | 0.682 |
| Futile recanalization‡ | 61 (30.3%) | 23 (18.5%) | 38 (49.4%) | <0.001 |
| sICH | 26 (10.2%) | 12 (7.8%) | 14 (13.9%) | 0.117 |
†
Data available in 79%.
‡
Data available in 78%.
mRS, modified Rankin Scale; TIMI, Thrombolysis in Myocardial Infarction; sICH, symptomatic intracerebral hemorrhage.
The outcome was assessed at 3 months. Futile recanalization was determined as successful recanalization but ending up with a poor outcome (modified Rankin Scale 4–6). Symptomatic intracranial hemorrhage (sICH) was defined according to European Cooperative Acute Stroke Study II (ECASS II) criteria.
Statistically significant p-values (<0.05) are bolded.